Aβ-IN-1

Aβ-IN-1

• CAS Number: 2766509-32-2
• UNSPSC Description: Aβ-IN-1 is a Aβ1–42 aggregation inhibitor. Aβ-IN-1 inhibits Aβ1-42 self-aggregation in vitro by delaying the exponential growth phase or reduces the quantity of fibrils in the steady state. Aβ-IN-1 can be used for the research of conformational disorders[1].
• Target Antigen: Amyloid-β
• Type: Reference compound
• Related Pathways: Neuronal Signaling
• Applications: Neuroscience-Neurodegeneration
• Field of Research: Neurological Disease
• Assay Protocol: https://www.medchemexpress.com/aβ-in-1.html
• Solubility: 10 mM in DMSO
• Smiles: C[C@@]12[C@]3([H])[C@](CC=C1C4=C(C)C5=CC=CC=C5N=C4CC2)([H])[C@@]6([H])[C@](CC3)([C@@](CC6)([H])[C@H](C)CCCC(C)C)C
• Molecular Weight: 483.77
• References & Citations: [1]Hélio M T Albuquerque, et al. Steroid-Quinoline Hybrids for Disruption and Reversion of Protein Aggregation Processes. ACS Med Chem Lett. 2022 Feb 14;13(3):443-448.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported